| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |